Dual Contribution of Quantitative Image Analysis for the Evaluation of HER2 IHC Staining Quality, and Interpretation of HER2 Overexpression and HER2-Low Status in Breast Carcinoma

被引：0
|
作者：
Cossutta, Melissande [1 ]
Truumees, Birgit [2 ]
Papine, Alexandre [1 ]
Kristoffersen, Heidi [2 ]
Tatarinova, Ekaterina [1 ]
Homsy, Charles [1 ]
Nielsen, Soren [2 ]
Soussaline, Francoise [1 ]
机构：
[1] IMSTAR Dx, Paris, France
[2] NordiQC, Aalborg, Denmark
来源：
LABORATORY INVESTIGATION | 2024年 / 104卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
117
引用
收藏
页码：S139 / S140
页数：2
相关论文
共 50 条
  • [31] Breast Carcinoma, Receptor Status, and Her2 neu Overexpression Revisited
    Puvitha, R. D.
    Shifa, S.
    INTERNATIONAL JOURNAL OF SCIENTIFIC STUDY, 2016, 3 (10) : 52 - 58
  • [32] Role of HER2 gene overexpression in breast carcinoma
    Ménard, S
    Tagliabue, E
    Campiglio, M
    Pupa, SM
    JOURNAL OF CELLULAR PHYSIOLOGY, 2000, 182 (02) : 150 - 162
  • [33] HER2 Dual ISH Determination of HER2 Gene Status in Breast Cancer: Interobserver Reproducibility
    Limbach, A. A. Lott
    Downs-Kelly, E. P.
    Papouchado, B. G.
    Tubbs, R. R.
    Lanigan, C.
    Booth, C. N.
    LABORATORY INVESTIGATION, 2012, 92 : 52A - 52A
  • [34] HER2 Dual ISH Determination of HER2 Gene Status in Breast Cancer: Interobserver Reproducibility
    Limbach, A. A. Lott
    Downs-Kelly, E. P.
    Papouchado, B. G.
    Tubbs, R. R.
    Lanigan, C.
    Booth, C. N.
    MODERN PATHOLOGY, 2012, 25 : 52A - 52A
  • [35] Inconsistency of HER2 Status Between Core Needle Biopsy and Surgical Specimens: Focus on HER2 Null, HER2 Ultralow, and HER2 Low
    Wu, Si
    Liu, Hongbo
    Liu, Yueping
    LABORATORY INVESTIGATION, 2025, 105 (03)
  • [36] HER2-low Breast Cancers: Comparison of HER2 Scores by Immunohistochemistry and Oncotype DX
    Chen, Hui
    Wu, Yun
    Ding, Qingqing
    Huo, Lei
    Khazai, Laila
    Sahin, Aysegul
    Albarracin, Constance
    LABORATORY INVESTIGATION, 2023, 103 (03) : S114 - S114
  • [37] Comparative Analysis of Four Immunohistochemical Assays for HER2 Expression in Breast Carcinoma - Correlation with HER2 Gene Amplification and Perspectives for HER2 Low Expression
    Nielsen, Soren
    Wang, Diana
    Calero, Valeria Montalvo
    LaMar, Jared
    Saxena, Ashish
    Decamillis, Rina
    Stensballe, Mia
    LABORATORY INVESTIGATION, 2023, 103 (03) : S192 - S192
  • [38] Is HER2 Evaluation with the CellSearch System a Method Reliable for Detecting HER2 Overexpression?
    Sandri, M. T.
    Zorzino, L.
    Cassatella, M. C.
    Dell'Orto, P.
    Stufano, V.
    Munzone, E.
    Casadio, C.
    CANCER RESEARCH, 2010, 70
  • [39] Breast Cancer with Equivocal HER2 IHC: Does HER2 IHC Intensity Identify Areas with FISH Amplification?
    Hertel, Johann D.
    Kaiser-Rogers, Kathleen
    O'Connor, Siobhan
    Calhoun, Benjamin
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 173 - 173
  • [40] Reassessment of HER2 status in breast cancer patients with initially HER2 negative or HER2 unknown primary tumors at the time of metastatic disease by serum HER2 and HER2 status of circulating tumor cells
    Fehm, T.
    Solomayer, E.
    Uhr, J.
    Wallwiener, D.
    ONKOLOGIE, 2008, 31 : 51 - 51
12345